Fluticasone+Salmeterol Cipla 250/25 fluticasone propionate/salmeterol (as xinafoate) 250/25 microgram inhalation pressurised aerosol can metered dose (267107)

ARTG ID 267107

ARTG Name

Fluticasone+Salmeterol Cipla 250/25 fluticasone propionate/salmeterol (as xinafoate) 250/25 microgram inhalation pressurised aerosol can metered dose

Product name

Fluticasone+Salmeterol Cipla 250/25 fluticasone propionate/salmeterol (as xinafoate) 250/25 microgram inhalation pressurised aerosol can metered dose

ARTG Date

15 December 2016

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

fluticasone propionate

salmeterol xinafoate

Licence category

RE

Licence status

A

Summary

Product information

Consumer medicine information

Related information

Fluticasone+Salmeterol Cipla 250/25 fluticasone propionate/salmeterol (as xinafoate) 250/25 microgram inhalation pressurised aerosol can metered dose, Cipla Australia Pty Ltd, CON-131

15 January 2017

Section 14 consent

Consent to while noncompliant with standards.
Fluticasone+Salmeterol Cipla 250/25 fluticasone propionate/salmeterol (as xinafoate) 250/25 microgram inhalation pressurised aerosol can metered dose, Cipla Australia Pty Ltd, CON-662

30 October 2020

Section 14 consent

Consent to while noncompliant with standards.
Fluticasone+Salmeterol Cipla 250/25 fluticasone propionate/salmeterol (as xinafoate) 250/25 microgram inhalation pressurised aerosol can metered dose, Cipla Australia Pty Ltd, CON-662

30 October 2020

Section 14 consent

Consent to while noncompliant with standards.